The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Investors understand that their principal will be at very high risk
Category
Sector Funds
Launch Date
27-Dec-24
Scheme Benchmark
NA
AUM ( in Cr.)
332.33
portfolio price to book value
9.89
investing style?
Large Growth
fund manager?
Nimesh Chandan,Sorbh Gupta,Siddharth Chaudhary
inception date (regular plan)
expense ratio (regular plan) %
2.37